134 related articles for article (PubMed ID: 10388474)
1. Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables.
Virtanen A; Gomari M; Kranse R; Stenman UH
Clin Chem; 1999 Jul; 45(7):987-94. PubMed ID: 10388474
[TBL] [Abstract][Full Text] [Related]
2. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.
Finne P; Finne R; Auvinen A; Juusela H; Aro J; Määttänen L; Hakama M; Rannikko S; Tammela TL; Stenman U
Urology; 2000 Sep; 56(3):418-22. PubMed ID: 10962306
[TBL] [Abstract][Full Text] [Related]
3. Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination.
Finne P; Auvinen A; Aro J; Juusela H; Määttänen L; Rannikko S; Hakama M; Tammela TL; Stenman UH
Eur Urol; 2002 Jun; 41(6):619-26; discussion 626-7. PubMed ID: 12074779
[TBL] [Abstract][Full Text] [Related]
4. Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening.
Finne P; Finne R; Bangma C; Hugosson J; Hakama M; Auvinen A; Stenman UH
Int J Cancer; 2004 Aug; 111(2):310-5. PubMed ID: 15197788
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic algorithm based on a multivariate model to reduce the percentage of negative prostatic biopsies in patients with changed PSA or suspicious rectal palpation].
Valer Algarabel J; Agüera Fernández L; Adot Zurbano JM; Virseda Chamorro M; Marcos Díez J; Gómez López A; Alpuente Román C
Actas Urol Esp; 2000; 24(7):549-59. PubMed ID: 11011445
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations.
Stephan C; Xu C; Finne P; Cammann H; Meyer HA; Lein M; Jung K; Stenman UH
Urology; 2007 Sep; 70(3):596-601. PubMed ID: 17688922
[TBL] [Abstract][Full Text] [Related]
7. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
8. Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer.
Potter SR; Horniger W; Tinzl M; Bartsch G; Partin AW
Urology; 2001 Jun; 57(6):1100-4. PubMed ID: 11377318
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
[TBL] [Abstract][Full Text] [Related]
10. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
[TBL] [Abstract][Full Text] [Related]
11. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
[TBL] [Abstract][Full Text] [Related]
14. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer detection at low prostate specific antigen.
Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
[TBL] [Abstract][Full Text] [Related]
16. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
[TBL] [Abstract][Full Text] [Related]
17. [Statistical study of probabilities of rectal palpation, total PSA, and PSA density in prostate cancer].
Ortiz Cabria R; Adriazola Semino M; Tejeda Bañez E; Alonso Villalba A; García Cobo E; Romero Rodríguez F; Monfá Bosch JM
Arch Esp Urol; 2002; 55(1):35-40. PubMed ID: 11957749
[TBL] [Abstract][Full Text] [Related]
18. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):773-8. PubMed ID: 7502414
[TBL] [Abstract][Full Text] [Related]
19. PSA density improves prediction of prostate cancer.
Verma A; St Onge J; Dhillon K; Chorneyko A
Can J Urol; 2014 Jun; 21(3):7312-21. PubMed ID: 24978363
[TBL] [Abstract][Full Text] [Related]
20. Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study.
Porter CR; O'Donnell C; Crawford ED; Gamito EJ; Sentizimary B; De Rosalia A; Tewari A
Urology; 2002 Nov; 60(5):831-5. PubMed ID: 12429310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
